Kristin Stephens - 18 Nov 2024 Form 4 Insider Report for Syros Pharmaceuticals, Inc. (SYRS)

Signature
/s/ Todd Rosenthal, as attorney-in-fact
Issuer symbol
SYRS
Transactions as of
18 Nov 2024
Net transactions value
-$7,949
Form type
4
Filing time
20 Nov 2024, 17:00:16 UTC
Previous filing
04 Nov 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SYRS Common Stock Sale $7,949 -36,133 -100% $0.2200 0 18 Nov 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.